SG11201900210PA - Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same - Google Patents

Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same

Info

Publication number
SG11201900210PA
SG11201900210PA SG11201900210PA SG11201900210PA SG11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA SG 11201900210P A SG11201900210P A SG 11201900210PA
Authority
SG
Singapore
Prior art keywords
composition
production method
same
immune function
acquired immune
Prior art date
Application number
SG11201900210PA
Inventor
Hiroshi Kido
Etsuhisa TAKAHASHI
Seiya Makino
Hiroshi Kano
Jun Henmi
Original Assignee
Meiji Co Ltd
Univ Tokushima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd, Univ Tokushima filed Critical Meiji Co Ltd
Publication of SG11201900210PA publication Critical patent/SG11201900210PA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/123Bulgaricus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/137Delbrueckii
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG11201900210PA 2016-08-17 2017-08-15 Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same SG11201900210PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016159824A JP6777911B2 (en) 2016-08-17 2016-08-17 Fermented milk for suppressing the decrease in immune function acquired by anti-influenza drugs and its manufacturing method
PCT/JP2017/029355 WO2018034279A1 (en) 2016-08-17 2017-08-15 Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same

Publications (1)

Publication Number Publication Date
SG11201900210PA true SG11201900210PA (en) 2019-02-27

Family

ID=61196651

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201900210PA SG11201900210PA (en) 2016-08-17 2017-08-15 Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same

Country Status (5)

Country Link
US (1) US20190150463A1 (en)
JP (1) JP6777911B2 (en)
CN (1) CN109475585A (en)
SG (1) SG11201900210PA (en)
WO (1) WO2018034279A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100278795A1 (en) * 2007-11-19 2010-11-04 Kaneka Corporation Lactic acid bacterium-containing preparation
EP3040083B1 (en) * 2013-08-26 2018-11-21 Meiji Co., Ltd. Antibody titer-increasing agent using lactic acid bacterium

Also Published As

Publication number Publication date
CN109475585A (en) 2019-03-15
WO2018034279A1 (en) 2018-02-22
JP2018027904A (en) 2018-02-22
JP6777911B2 (en) 2020-10-28
US20190150463A1 (en) 2019-05-23

Similar Documents

Publication Publication Date Title
IL250744A0 (en) Method of producing palbociclib and pharmaceutical compositions comprising the same
EP3397260A4 (en) Methods and compositions relating to chondrisomes from blood products
ZA201608077B (en) Combination, composition, and method of administering the combination or composition to animals
PL3442480T3 (en) Topical administration method
EP3302783A4 (en) Production of metal-organic frameworks
GB201612853D0 (en) Solid dosage form production
HK1231416A1 (en) Complexes of sirolimus and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HK1232229A1 (en) Novel compound of 4-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof 4-
EP3156037A4 (en) Alpha-gel-intermediate composition, and production method for alpha-gel-containing o/w emulsion cosmetic using said composition
PL3309138T3 (en) Method for co-production of 2,3,3,3-tetrafluoropropylene and 1,3,3,3-tetrafluoropropylene
EP3156043A4 (en) A-gel-intermediate composition, and production method for a-gel-containing o/w emulsion cosmetic using said composition
HK1256362A1 (en) Cocrystal, production method thereof, and medicament containing cocrystal
PT3202759T (en) Alpha-aminoamide derivative compound and pharmaceutical composition comprising same
SI3672770T1 (en) Method for the production of curved furniture components
EP3206771C0 (en) Method for adjusting the composition of chromatography products
EP3538126A4 (en) Bacteriocin production, compositions and methods of use
EP3170794A4 (en) Composition including silicotitanate having sitinakite structure, and production method for same
IL249010A0 (en) Pharmaceutical composition comprising pyrazine carboxamide compound as active ingredient
EP3347380A4 (en) Enhanced delivery of drugs to the brain
HK1223837A1 (en) Compositions and methods for reducing overdose
HK1214767A1 (en) Tablet-formed pharmaceutical composition and preparation method thereof
EP3378493A4 (en) Novel anti-cancer drug nano-preparation and preparation method therefor
EP3151826A4 (en) Omega-3 compositions, dosage forms, and methods of use
EP3398949A4 (en) Uses of compound in preparation of drugs for treating brain glioma
SG11201900210PA (en) Composition for controlling acquired immune function suppression due to anti-influenza drug, and production method for same